£495.00

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in Japan

Price data last checked 77 day(s) ago - refreshing...

View at Amazon

Price History & Forecast

Last 14 days • 14 data points (No recent data available)

Historical
Generating forecast...
£495.00 £470.25 £480.15 £490.05 £499.95 £509.85 £519.75 26 January 2026 29 January 2026 01 February 2026 04 February 2026 08 February 2026

Price Distribution

Price distribution over 14 days • 1 price levels

Days at Price
14 days 0 4 7 11 14 £495 Days at Price

Price Analysis

Most common price: £495 (14 days, 100.0%)

Price range: £495 - £495

Price levels: 1 different prices over 14 days

Product Specifications

Format
Paperback
Domain
Amazon UK
Release Date
28 November 2022
Listed Since
08 December 2022

Similar Products You Might Like

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan
98% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Chemotherapy Therapeutics in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan
97% match

The 2023-2028 Outlook for Antiemetic Chemotherapy Drugs in Japan

£495.00 16 Dec 2025
The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan
97% match

The 2023-2028 Outlook for Cancer Supportive Care Drugs in Japan

£495.00 19 Apr 2026
The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan
97% match

The 2023-2028 Outlook for HER-2 Positive Breast Cancer Chemotherapy in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for External Beam Radiation Oncology Therapies in Japan
97% match

The 2023-2028 Outlook for External Beam Radiation Oncology Therapies in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in Japan
97% match

The 2023-2028 Outlook for Chemotherapy-Induced Nausea and Vomiting Drugs in Japan

£495.00 22 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan
97% match

The 2023-2028 Outlook for Multiple Myeloma Therapeutics in Japan

£495.00 10 Jan 2026
The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan
97% match

The 2023-2028 Outlook for Natural Killer Cell Therapeutics in Japan

£495.00 25 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan
97% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma Treatments in Japan

£495.00 24 Jan 2026
The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan
97% match

The 2023-2028 Outlook for Monoclonal Antibodies Protein Therapeutics in Japan

£495.00 09 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin's Lymphoma and Chronic Lymphoma Treatments in Japan

£495.00 22 Jan 2026
The 2023-2028 Outlook for External Beam Radiotherapy in Japan
96% match

The 2023-2028 Outlook for External Beam Radiotherapy in Japan

£495.00 12 Jan 2026
The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in Japan
96% match

The 2023-2028 Outlook for Chemotherapy-Induced Serotonin Receptor Antagonists for Nausea and Vomiting Drugs in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Internal Beam Radiotherapy in Japan
96% match

The 2023-2028 Outlook for Internal Beam Radiotherapy in Japan

£495.00 11 Jan 2026
The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China
96% match

The 2023-2028 Outlook for Chemotherapy and Antibody Combination Antibody Therapies in China

£495.00 07 Jan 2026
The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan
96% match

The 2023-2028 Outlook for Uterine Cancer Therapeutics and Diagnostics in Japan

£495.00 26 Jan 2026
The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan
96% match

The 2023-2028 Outlook for Non-Hodgkin Lymphoma in Japan

£495.00 27 Jan 2026
The 2023-2028 Outlook for Proton Therapies in Japan - Book
96% match

The 2023-2028 Outlook for Proton Therapies in Japan - Book

£495.00 07 Mar 2026
The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan
96% match

The 2023-2028 Outlook for Targeted Therapy Liver Cancer Drugs in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan
96% match

The 2023-2028 Outlook for Advanced Therapy Medicinal Products in Japan

£495.00 09 Jan 2026
The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in Japan
96% match

The 2023-2028 Outlook for Bile Duct Cancer (Cholangiocarcinoma) Treatments in Japan

£495.00 07 Jan 2026
The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan
96% match

The 2023-2028 Outlook for Multiple Myeloma Treatments in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for Compact Advance Radiotherapy Systems in Japan
96% match

The 2023-2028 Outlook for Compact Advance Radiotherapy Systems in Japan

£495.00 13 Jan 2026
The 2023-2028 Outlook for HPV and CMV Therapeutics in Japan
96% match

The 2023-2028 Outlook for HPV and CMV Therapeutics in Japan

£495.00 07 Jan 2026